Effects of green tea on lipid metabolism in overweight or obese people: A meta-analysis of randomized controlled trials

Molecular Nutrition and Food Research

Volumn 62, Issue 1, 2018, Pages

  Yuan, Fen ^a   Dong, Hui ^a   Fang, Ke ^a   Gong, Jing ^a   Lu, Fuer ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Green tea; Lipid metabolism; Meta analysis; Obese; Overweight

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; BLOOD; CHILD; HUMAN; LIPID METABOLISM; META ANALYSIS; METABOLISM; MIDDLE AGED; OBESITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); TEA; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; HUMANS; LIPID METABOLISM; MIDDLE AGED; OBESITY; OVERWEIGHT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TEA; TRIGLYCERIDES; YOUNG ADULT;

EID: 85040374361     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201601122     Document Type: Article

References (70)

1. Cheng, T. O., Obesity crisis comprised of danger and opportunity. J. Am. Diet. Assoc. 2004, 104, 1546.
2. Kang, Y. J., Wang, H. W.,Cheon, S. Y., Lee, H. J. et al., Associations of obesity and dyslipidemia with intake of sodium, fat, and sugar among Koreans: a qualitative systematic review. Clin. Nutr. Res. 2016, 5, 290–304.
3. Flegal, K. M., Carroll, M. D., Kit, B. K., Ogden, C. L., Prevalence of obesity and trends in the distribution of body mass index among US Adults, 1999–2010. JAMA 2012, 307, 491–497.
4. Finkelstein, E. A., Trogdon, J. G., Cohen, J. W., Dietz, W., Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff (Millwood) 2009, 28, w822–w831.
5. Apovian, C. M., The Obesity Epidemic–understanding the disease and the treatment. N. Engl. J. Med. 2016, 374, 177–179.
6. Uerlich, M. F., Yumuk, V., Finer, N., Basdevant, A. et al., Obesity management in Europe: current status and objectives for the future. Obes. Facts. 2016, 9, 273–283.
7. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Am J Clin Nutr. 1998, 68, 899–917.
8. Haskell, W. L., Cardiovascular disease prevention and lifestyle interventions: effectiveness and efficacy. J. Cardiovasc. Nurs. 2003, 18, 245–255.
9. Kang, Y. J., Wang, H. W., Cheon, S. Y., Lee, H. J. et al., Associations of obesity and dyslipidemia with intake of sodium, fat, and sugar among koreans: a qualitative systematic review. Clin. Nutr. Res. 2016, 5, 290–304.
10. Casavalle, P. L., Lifshitz, F., Romano, L. S., Pandolfo, M. et al., Prevalence of dyslipidemia and metabolic syndrome risk factor in overweight and obese children. Pediatr. Endocrinol. Rev. 2014, 12, 213–223.
11. Reuter, C. P., Da, S. P., Renner, J. D., de Mello, E. D. et al., Dyslipidemia is associated with unfit and overweight-obese children and adolescents. ARQ BRAS Cardiol. 2016, 106, 188–193.
12. Anderson, T. J., Mancini, G. B., Genest, J. J., Gregoire, J. et al., The new dyslipidemia guidelines: what is the debate? Can. J. Cardiol. 2015, 31, 605–612.
13. Mietus-Snyder, M., Drews, K. L., Otvos, J. D., Willi, S. M. et al., Low-density lipoprotein cholesterol versus particle number in middle school children. J. Pediatr. 2013, 163, 355–362.
14. Luscher, T. F., Landmesser, U., von Eckardstein, A., Fogelman, A. M., High-density lipoprotein: vascular protective effects, dysfunction, and potential as therapeutic target. Circ. Res. 2014, 114, 171–182.
15. Acevedo, M., Kramer, V., Tagle, R., Corbalan, R. et al., [Total/HDL cholesterol ratio and non HDL cholesterol as predictors for increased intima media thickness]. Rev. Med. Chil. 2012, 140, 969–976.
16. de Ferranti, S. D., Milliren, C. E., Denhoff, E. R., Steltz, S. K. et al., Using high-dose omega-3 fatty acid supplements to lower triglyceride levels in 10- to 19-year-olds. Clin. Pediatr (Phila). 2014, 53, 428–438.
17. Mancini, G. B., Tashakkor, A. Y., Baker, S., Bergeron, J. et al., Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus update. Can. J. Cardiol. 2013, 29, 1553–1568
18. Chaipichit, N., Krska, J., Pratipanawatr, T., Jarernsiripornkul, N., Statin adverse effects: patients' experiences and laboratory monitoring of muscle and liver injuries. Int. J. Clin. Pharm. 2015, 37, 355–364.
19. Julius, U., Niacin as antidyslipidemic drug. Can. J. Physiol. Pharmacol. 2015, 93, 1043–1054.
20. Cheng, T. O., All teas are not created equal: the Chinese green tea and cardiovascular health. INT J. Cardiol. 2006, 108, 301–308.
21. Jiang, H., Engelhardt, U. H., Thrane, C., Maiwald, B. et al., Determination of flavonol glycosides in green tea, oolong tea and black tea by UHPLC compared to HPLC. Food Chem. 2015, 183, 30–35.
22. Liu, K., Zhou, R., Wang, B., Chen, K. et al., Effect of green tea on glucose control and insulin sensitivity: a meta-analysis of 17 randomized controlled trials. Am. J. Clin. Nutr. 2013, 98, 340–348.
23. Sang, S., Lambert, J. D., Ho, C. T., Yang, C. S., The chemistry and biotransformation of tea constituents. Pharmacol. Res. 2011, 64, 87–99.
24. Khan, N., Mukhtar, H., Tea polyphenols for health promotion. Life Sci. 2007, 81, 519–533.
25. Balentine, D. A., Wiseman, S. A., Bouwens, L. C., The chemistry of tea flavonoids. Crit. Rev. Food Sci. Nutr. 1997, 37, 693–704.
26. Riegsecker, S., Wiczynski, D., Kaplan, M. J., Ahmed, S., Potential benefits of green tea polyphenol EGCG in the prevention and treatment of vascular inflammation in rheumatoid arthritis. Life Sci. 2013, 93, 307–312.
27. Li, G., Zhang, Y., Mbuagbaw, L., Holbrook, A. et al., Effect of green tea supplementation on blood pressure among overweight and obese adults: a protocol for a systematic review. BMJ Open 2014, 4, e4971.
28. Butt, M. S., Ahmad, R. S., Sultan, M. T., Qayyum, M. M. et al., Green tea and anticancer perspectives: updates from last decade. Crit. Rev. Food Sci. Nutr. 2015, 55, 792–805.
29. Huang, J., Wang, Y., Xie, Z., Zhou, Y. et al., The anti-obesity effects of green tea in human intervention and basic molecular studies. Eur. J. Clin. Nutr. 2014, 68, 1075–1087.
30. Sae-tan, S., Grove, K. A., Lambert, J. D., Weight control and prevention of metabolic syndrome by green tea. Pharmacol. Res. 2011, 64, 146–154.
31. Wang, S., Moustaid-Moussa, N., Chen, L., Mo, H. et al., Novel insights of dietary polyphenols and obesity. J. Nutr. Biochem. 2014, 25, 1–18.
32. Suzuki-Sugihara, N., Kishimoto, Y., Saita, E., Taguchi, C. et al., Green tea catechins prevent low-density lipoprotein oxidation via their accumulation in low-density lipoprotein particles in humans. Nutr. Res. 2016, 36, 16–23.
33. Hsu, C. H., Liao, Y. L., Lin, S. C., Tsai, T. H. et al., Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebo-controlled clinical trial. Altern. Med. Rev. 2011, 16, 157–163.
34. Mielgo-Ayuso, J., Barrenechea, L., Alcorta, P., Larrarte, E. et al., Effects of dietary supplementation with epigallocatechin-3-gallate on weight loss, energy homeostasis, cardiometabolic risk factors and liver function in obese women: randomised, double-blind, placebo-controlled clinical trial. Br. J. Nutr. 2014, 111, 1263–1271.
35. Diepvens, K., Kovacs, E. M., Vogels, N., Westerterp-Plantenga, M. S., Metabolic effects of green tea and of phases of weight loss. Physiol. Behav. 2006, 87, 185–191.
36. Brown, A. L., Lane, J., Coverly, J., Stocks, J. et al., Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial. Br. J. Nutr. 2009, 101, 886–894.
37. Vieira, S. A., Schwanke, C. H., Gomes, I., Valle, G. M., Effect of green tea (Camellia sinensis) consumption on the components of metabolic syndrome in elderly. J. Nutr. Health Aging. 2012, 16, 738–742.
38. Tsuchida, T., Itakura, H., Nakamura, H., Reduction of body fat in humans by long-term ingestion of catechins. Progress in Medicine 2002, 22, 1–25.
39. Brown, A. L., Lane, J., Holyoak, C., Nicol, B. et al., Health effects of green tea catechins in overweight and obese men: a randomised controlled cross-over trial. Br. J. Nutr. 2011, 106, 1880–1889.
40. Basu, A., Du M, Sanchez, K., Leyva, M. J. et al., Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome. Nutrition 2011, 27, 206–213.
41. Sanchez, K. R., The effects of green tea supplementation in subjects with metabolic syndrome in Oklahoma. (http://hdl.handle.net/11244/9274) (accessed: July 2017).
42. Stendell-Hollis, N. R., Thomson, C. A., Thompson, P. A., Bea, J. W. et al., Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors. J. Hum. Nutr. Diet 2010, 23, 590–600.
43. Nagao, T., Hase, T., Tokimitsu, I., A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity (Silver Spring) 2007, 15, 1473–1483.
44. Chen, I. J., Liu, C. Y., Chiu, J. P., Hsu, C. H., Therapeutic effect of high-dose green tea extract on weight reduction: a randomized, double-blind, placebo-controlled clinical trial. Clin. Nutr. 2016, 35, 592–599.
45. Matsuyama, T., Tanaka, Y., Kamimaki, I., Nagao, T. et al., Catechin safely improved higher levels of fatness, blood pressure, and cholesterol in children. Obesity (Silver Spring) 2008, 16, 1338–1348.
46. Hsu, C. H., Tsai, T. H., Kao, Y. H., Hwang, K. C. et al., Effect of green tea extract on obese women: a randomized, double-blind, placebo-controlled clinical trial. Clin. Nutr. 2008, 27, 363–370.
47. Bogdanski, P., Suliburska, J., Szulinska, M., Stepien, M. et al., Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients. Nutr. Res. 2012, 32, 421–427.
48. Suliburska, J., Bogdanski, P., Szulinska, M., Stepien, M. et al., Effects of green tea supplementation on elements, total antioxidants, lipids, and glucose values in the serum of obese patients. Biol. Trace Elem. Res. 2012, 149, 315–322.
49. Di Pierro, F., Menghi, A. B., Barreca, A., Lucarelli, M. et al., Greenselect Phytosome as an adjunct to a low-calorie diet for treatment of obesity: a clinical trial. Altern. Med. Rev. 2009, 14, 154–160.
50. G, B., A, L., S, H., MR, C. et al., Greenselect phytosome for borderline metabolic syndrome. Evid-Based Compl. Alt. 2013. https://doi.org/10.1155/2013/869061.
51. Tsai, C., Chiu, W. C., Yang, N. C., Ouyang, C. M. et al., A novel green tea meal replacement formula for weight loss among obese individuals: a randomized controlled clinical trial. Int. J. Food Sci. Nutr. 2009, 60 Suppl 6, 151–159.
52. Maki, K. C., Reeves, M. S., Farmer, M., Yasunaga, K. et al., Green tea catechin consumption enhances exercise-induced abdominal fat loss in overweight and obese adults. J. Nutr. 2009, 139, 264–270.
53. Zheng, X. X., Xu, Y. L., Li, S. H., Hui, R. et al., Effects of green tea catechins with or without caffeine on glycemic control in adults: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 2013, 97, 750–762.
54. Higgins, J. P. T., Green, S. (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-hanhanhandbook.org.
55. Higgins, J. P., Thompson, S. G., Deeks, J. J., Altman, D. G., Measuring inconsistency in meta-analyses. BMJ 2003, 327, 557–560.
56. Mousavi, A., Vafa, M., Neyestani, T., Khamseh, M. et al., The effects of green tea consumption on metabolic and anthropometric indices in patients with Type 2 diabetes. J. Res. Med. Sci. 2013, 18, 1080–1086.
57. Kim, A., Chiu, A., Barone, M. K., Avino, D. et al., Green tea catechins decrease total and low-density lipoprotein cholesterol: a systematic review and meta-analysis. J. Am. Diet Assoc. 2011, 111, 1720–1729.
58. Onakpoya, I., Spencer, E., Heneghan, C., Thompson, M., The effect of green tea on blood pressure and lipid profile: a systematic review and meta-analysis of randomized clinical trials. Nutr. Metab. Cardiovasc. Dis. 2014, 24, 823–836.
59. Khalesi, S., Sun, J., Buys, N., Jamshidi, A. et al., Green tea catechins and blood pressure: a systematic review and meta-analysis of randomised controlled trials. Eur. J. Nutr. 2014, 53, 1299–1311.
60. Samavat, H., Newman, A. R., Wang, R., Yuan, J. M. et al., Effects of green tea catechin extract on serum lipids in postmenopausal women: a randomized, placebo-controlled clinical trial. Am. J. Clin. Nutr. 2016, 104, 1671–1682.
61. Chen, Y. K., Cheung, C., Reuhl, K. R., Liu, A. B. et al., Effects of green tea polyphenol (-)-epigallocatechin-3-gallate on newly developed high-fat/Western-style diet-induced obesity and metabolic syndrome in mice. J. Agric. Food Chem. 2011, 59, 11862–11871.
62. Bose, M., Lambert, J. D., Ju, J., Reuhl, K. R. et al., The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. J. Nutr. 2008, 138, 1677–1683.
63. Zheng, X. X., Xu, Y. L., Li, S. H., Liu, X. X. et al., Green tea intake lowers fasting serum total and LDL cholesterol in adults: a meta-analysis of 14 randomized controlled trials. Am. J. Clin. Nutr. 2011, 94, 601–610.
64. Stelmach-Mardas, M., Walkowiak, J., Dietary interventions and changes in cardio-metabolic parameters in metabolically healthy obese subjects: a systematic review with meta-analysis. Nutrients 2016, 8, 455.
65. Sonego, M., Sagrado, M. J., Escobar, G., Lazzerini, M. et al., Dyslipidemia, diet and physical exercise in children on treatment with antiretroviral medication in El Salvador: a cross-sectional study. Pediatr. Infect. Dis. J. 2016, 35, 1111–1116.
66. Kim, H. Y., Lee, M. Y., Park, H. M., Park, Y. K. et al., Urine and serum metabolite profiling of rats fed a high-fat diet and the anti-obesity effects of caffeine consumption. Molecules 2015, 20, 3107–3128.
67. Zhao, Y., Yang, L., Huang, Z., Lin, L. et al., Synergistic effects of caffeine and catechins on lipid metabolism in chronically fed mice via the AMP-activated protein kinase signaling pathway. Eur. J. Nutr. 2016. https://doi.org/10.1007/s00394-016-1271-4.
68. Ostrowska, J., Skrzydlewska, E., The comparison of effect of catechins and green tea extract on oxidative modification of LDL in vitro. Adv. Med. Sci. 2006, 51, 298–303.
69. Eichenberger, P., Mettler, S., Arnold, M., Colombani, P. C., No effects of three-week consumption of a green tea extract on time trial performance in endurance-trained men. Int. J. Vitam. Nutr. Res. 2010, 80, 54–64.
70. Chan, C. C., Koo, M. W., Ng, E. H., Tang, O. S. et al., Effects of Chinese green tea on weight, and hormonal and biochemical profiles in obese patients with polycystic ovary syndrome–a randomized placebo-controlled trial. J. Soc. Gynecol. Investig. 2006, 13, 63–68.